This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated revenue up 10% from Q2 FY26; EBITDA margin expands to 19.2%
LAXMIDENTL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 0.9 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 September 2026, revenue from operations rose 10.0% year on year to INR 79.52 crore from INR 72.27 crore. EBITDA rose 38.5% to INR 15.27 crore and margin expanded to 19.2% from 15.3%; profit after tax rose 17.6% to INR 10.04 crore. For consolidated H1 FY27, revenue rose 11.9% to INR 154.22 crore and profit after tax rose 20.7% to INR 20.35 crore. Scanner sales fell to INR 3.5 crore from INR 8.9 crore.
Positive: double-digit revenue and profit growth with a wider EBITDA margin may support sentiment, though lower scanner sales remain a concern.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹79.52 Cr | ₹72.27 Cr | +10.0% |
| Operating profit | ₹9.57 Cr | ₹7.04 Cr | +36.0% |
| Profit after tax | ₹10.04 Cr | ₹8.53 Cr | +17.6% |
| EBITDA margin | 19.2% | 15.3% | +3.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.